Roche Accused Of Setting Precedent On Drug Pricing
Critics argue that Roche is setting a precedent by demanding high prices for its innovative therapies. The Swiss Federal Office of Public Health (BAG) is negotiating drug prices based on legal frameworks, but Roche maintains an ethical responsibility to make life-saving treatments accessible. The drug in question is not unavailable, but the administrative process is causing distress.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
SRF 4 News
“Kritiker sagen, Roche statuiere ein Exempel. Sagt Jörg Indermitte, Leiterabteilung Arzt Neimittel, Krankenversicherung beim BAG.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade